等待开盘 02-04 09:30:00 美东时间
0.000
0.00%
今日重点评级关注:HC Wainwright & Co.:维持Praxis Precision Medicine"买入"评级,目标价从340美元升至1245美元;HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从10美元升至12美元
02-02 14:15
Keefe, Bruyette & Woods analyst Timothy Switzer maintains NewtekOne (NASDAQ:NEWT) with a Market Perform and raises the price target from $13 to $14.
01-30 23:21
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据NewtekOne业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 2025年总营收(净利息收入+非利息收入)达到2.84亿美元,同比增长10.6%(2024年为2.57亿美元)。 **盈利能力:** 2025年税前净收入约8000万美元,同比增长16.4%。每股收益表现突出,稀释每股收益达到2.18美元,同比大幅增长1211%。 **资产规模:** 控股公司合并总资产达到24.25亿美元,收购的银行资产规模为14.15亿美元,资产同比增长33%。 **存款业务:** 第四季度新开设9000个存款账户,全年商业存款增
01-30 12:07
NewtekOne (NASDAQ:NEWT) reported its Q4 earnings results on Thursday, January 2...
01-30 05:18
NewtekOne (NASDAQ:NEWT) announced its Q4 earnings on Thursday, January 29, 2026...
01-30 05:12
NewtekOne (NASDAQ:NEWT) reported quarterly earnings of $0.65 per share which missed the analyst consensus estimate of $0.68 by 4.83 percent. This is a 5.8 percent decrease over earnings of $0.69 per share from the same
01-30 05:04
Companies Reporting Before The Bell • MOGU (NYSE:MOGU) is estimated to report e...
01-29 19:11
NewtekOne (NASDAQ:NEWT) is preparing to release its quarterly earnings on Thurs...
01-29 04:02
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
Piper Sandler analyst Crispin Love maintains NewtekOne (NASDAQ:NEWT) with a Neutral and raises the price target from $12.5 to $13.
01-09 22:14